Unknown

Dataset Information

0

Frequency, subtypes distribution, and risk factors of Blastocystis spp. in COVID-19 patients in Tehran, capital of Iran: A case-control study.


ABSTRACT:

Background

Recent theories on the possible interactions between the intestinal parasites and COVID-19 have stated that these co-infections may cause immune imbalance and further complications in the affected patients. Until now, there is no data about Blastocystis subtypes as an intestinal parasite in COVID-19 patients. Therefore, the present work was done to evaluate the molecular prevalence of Blastocystis spp. and related risk factors in Iranian patients with COVID-19.

Method

Stool samples were gathered from 200 COVID-19 patients and 200 control, being matched regarding age, gender and residence. Then, stool samples were surveyed by parasitological methods, including direct slide smear and formalin-ether concentration. In the following, PCR and sequencing were used to detect Blastocystis spp. and their subtypes.

Results

The frequency of Blastocystis spp. in patients with COVID-19 (7.5%; 15/200 by molecular method vs. 6%; 12/200 by microscopy method) was slightly higher than in individuals without COVID-19 (4.5%; 9/200 by molecular method vs. 4%; 8/200 by microscopy method), this difference was not statistically significant (P value = 0.57 for molecular method vs. P value = 0.81 for microscopy method). Regarding associated factors for Blastocystis spp., we found significant differences regarding the residence (rural), loose and watery stool with diarrhea, and duration of treatment (6 weeks <) in the COVID-19 group. Blastocystis ST3 was the most common subtype in the patients with COVID-19 and control group.

Conclusions

Based on this results, health education, improved sanitation and good personal hygiene are highly recommended to prevent Blastocystis in COVID-19 patients.

SUBMITTER: Taghipour A 

PROVIDER: S-EPMC9733120 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Frequency, subtypes distribution, and risk factors of <i>Blastocystis</i> spp. in COVID-19 patients in Tehran, capital of Iran: A case-control study.

Taghipour Ali A   Pirestani Majid M   Hamidi Farahani Ramin R   Barati Mohammad M   Asadipoor Esfandiar E  

New microbes and new infections 20221209


<h4>Background</h4>Recent theories on the possible interactions between the intestinal parasites and COVID-19 have stated that these co-infections may cause immune imbalance and further complications in the affected patients. Until now, there is no data about <i>Blastocystis</i> subtypes as an intestinal parasite in COVID-19 patients. Therefore, the present work was done to evaluate the molecular prevalence of <i>Blastocystis</i> spp. and related risk factors in Iranian patients with COVID-19.<h  ...[more]

Similar Datasets

| S-EPMC10504051 | biostudies-literature
| S-EPMC6471993 | biostudies-literature
| S-EPMC7751524 | biostudies-literature
| S-EPMC8507199 | biostudies-literature
| S-EPMC9363254 | biostudies-literature
| S-EPMC6841765 | biostudies-literature
| S-EPMC10893338 | biostudies-literature
| S-EPMC4573284 | biostudies-literature
| S-EPMC7770537 | biostudies-literature
| S-EPMC9883249 | biostudies-literature